SARS-CoV-2 Infection of Salivary Glands Compromises Oral Antifungal Innate Immunity and Predisposes to Oral Candidiasis
Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunist...
Saved in:
Published in | bioRxiv |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article Paper |
Language | English |
Published |
United States
Cold Spring Harbor Laboratory
11.06.2024
|
Edition | 1.2 |
Subjects | |
Online Access | Get full text |
ISSN | 2692-8205 2692-8205 |
DOI | 10.1101/2024.05.13.593942 |
Cover
Loading…
Abstract | Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen
. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and
colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes.
hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral
burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of
. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of
in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of
was demonstrated using an
assay where
was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis. |
---|---|
AbstractList | Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.
Saliva contains antimicrobial peptides part of host innate immunity crucial for protection against colonizing microbial species. Most notable is the antifungal peptide histatin-5 produced in salivary glands cells. SARS-CoV-2 was shown to replicate in salivary gland cells causing tissue inflammation. In this study, we showed decreased expression of histatin genes in salivary glands from COVID-19 autopsies, and co-localization studies of SARS-CoV-2 spike and histatin revealed absence or minimal presence of histatin in acinar cells with replicating virus. To investigate the clinical implications of these findings, we conducted studies using saliva samples from subjects with mild to severe COVID-19, matched with healthy controls. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects with enhanced prevalence of C. albicans. Prospective analysis indicated the decrease in histatin-5 is reversible in mild-moderate disease, and salivary cytokine profiling demonstrated activation of the Th17 inflammatory pathway. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in saliva with low histatin-5, but not with high histatin-5. Collectively, the findings provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity and predisposition to oral candidiasis. Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen . Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of . Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of was demonstrated using an assay where was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis. Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis. |
Author | Rock, Peter Martin, Daniel Perez, Paola Sultan, Ahmed S Wang, Tristan W Stein, Sydney Jabra-Rizk, Mary Ann Chertow, Daniel S Hewitt, Stephen M Meiller, Timothy F Warner, Blake M Gasmi, Billel Kleiner, David E Alfaifi, Areej A Ramelli, Sabrina |
Author_xml | – sequence: 1 givenname: Areej A surname: Alfaifi fullname: Alfaifi, Areej A organization: King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia – sequence: 2 givenname: Tristan W surname: Wang fullname: Wang, Tristan W organization: Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland Baltimore, Maryland, United States of America – sequence: 3 givenname: Paola surname: Perez fullname: Perez, Paola organization: Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 4 givenname: Ahmed S surname: Sultan fullname: Sultan, Ahmed S organization: University of Maryland Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States of America – sequence: 5 givenname: Timothy F surname: Meiller fullname: Meiller, Timothy F organization: University of Maryland Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States of America – sequence: 6 givenname: Peter surname: Rock fullname: Rock, Peter organization: Department of Anesthesia, School of Medicine, University of Maryland Baltimore, Maryland, United States of America – sequence: 7 givenname: David E surname: Kleiner fullname: Kleiner, David E organization: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 8 givenname: Daniel S surname: Chertow fullname: Chertow, Daniel S organization: Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States of America, USA – sequence: 9 givenname: Stephen M surname: Hewitt fullname: Hewitt, Stephen M organization: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 10 givenname: Billel surname: Gasmi fullname: Gasmi, Billel organization: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 11 givenname: Sydney surname: Stein fullname: Stein, Sydney organization: Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA – sequence: 12 givenname: Sabrina surname: Ramelli fullname: Ramelli, Sabrina organization: Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA – sequence: 13 givenname: Daniel surname: Martin fullname: Martin, Daniel organization: Genomics and Computational Biology Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 14 givenname: Blake M surname: Warner fullname: Warner, Blake M organization: Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 15 givenname: Mary Ann orcidid: 0000-0002-4425-3873 surname: Jabra-Rizk fullname: Jabra-Rizk, Mary Ann organization: Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38798323$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkMtOwzAURC1UxKP0A9ggL9mkXNuxkyyrCEolpCIKbCM7dpBRYpc4KfTvSdXyWN2R7sxIZ87RyHlnELokMCUEyA0FGk-BTwmb8oxlMT1CZ1RkNEop8NE_fYomIbwDAM0EYUl8gk5ZmmQpo-wMfa5mT6so968RxQtXmbKz3mFf4ZWs7Ua2WzyvpdMB575Zt76xwQS8bGWNZ66zVe_eBrlwTnYGL5qmd7bb4iGAH1ujbVj7nb_z-0g-PKy2MthwgY4rWQczOdwxerm7fc7vo4flfJHPHiJFGKWRZkIkisSKCwVlynildSIyluqs5EzplIAmNKkk1VqWqQaiTKnKRIEQMXDGxuh636usb7_spli3thmwit18BfCCsGI_35914PzoTeiKgbY09cBvfB8KBgISDjRJB-vVwdqrxujf0p9d2TePRHsi |
ContentType | Journal Article Paper |
Copyright | 2024, Posted by Cold Spring Harbor Laboratory |
Copyright_xml | – notice: 2024, Posted by Cold Spring Harbor Laboratory |
DBID | NPM 7X8 FX. |
DOI | 10.1101/2024.05.13.593942 |
DatabaseName | PubMed MEDLINE - Academic bioRxiv |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: FX. name: bioRxiv url: https://www.biorxiv.org/ sourceTypes: Open Access Repository – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2692-8205 |
Edition | 1.2 |
ExternalDocumentID | 2024.05.13.593942v2 38798323 |
Genre | Journal Article Preprint |
GrantInformation_xml | – fundername: NIDCR NIH HHS grantid: R21 DE031888 – fundername: NIDCD NIH HHS grantid: R01 DC000086 – fundername: Intramural NIH HHS grantid: ZIC DC000086 – fundername: Intramural NIH HHS grantid: Z01 DE000704 – fundername: Intramural NIH HHS grantid: ZIA CL090070 |
GroupedDBID | 8FE 8FH AFKRA ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI CCPQU HCIFZ LK8 M7P NPM NQS PHGZT PIMPY PMFND PROAC RHI 7X8 PHGZM PQGLB PUEGO FX. |
ID | FETCH-LOGICAL-b1322-d3667b14b56b0c835fdd76938d9c53bd810d127fa2ddac8d01becbc7b06640533 |
IEDL.DBID | FX. |
ISSN | 2692-8205 |
IngestDate | Tue Jan 07 18:56:18 EST 2025 Fri Sep 05 14:57:55 EDT 2025 Sat May 31 02:13:28 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
License | This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at http://creativecommons.org/licenses/by-nd/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b1322-d3667b14b56b0c835fdd76938d9c53bd810d127fa2ddac8d01becbc7b06640533 |
Notes | ObjectType-Working Paper/Pre-Print-3 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interest Statement: The authors have declared no competing interest. |
ORCID | 0000-0002-4425-3873 |
OpenAccessLink | https://www.biorxiv.org/content/10.1101/2024.05.13.593942 |
PMID | 38798323 |
PQID | 3060750278 |
PQPubID | 23479 |
PageCount | 35 |
ParticipantIDs | biorxiv_primary_2024_05_13_593942 proquest_miscellaneous_3060750278 pubmed_primary_38798323 |
PublicationCentury | 2000 |
PublicationDate | 2024-Jun-11 20240611 |
PublicationDateYYYYMMDD | 2024-06-11 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-Jun-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | bioRxiv |
PublicationTitleAlternate | bioRxiv |
PublicationYear | 2024 |
Publisher | Cold Spring Harbor Laboratory |
Publisher_xml | – name: Cold Spring Harbor Laboratory |
References | Shen, Voigt, Goranova, Abed, Kleiner, Maldonado (2024.05.13.593942v2.29) 2023; 8 Vila, Sultan, Montelongo-Jauregui, Jabra-Rizk (2024.05.13.593942v2.20) 2020; 6 Salehi, Ahmadikia, Mahmoudi, Kalantari, Jamalimoghadamsiahkali, Izadi (2024.05.13.593942v2.3) 2020; 63 Situ, Bobek (2024.05.13.593942v2.18) 2000; 44 Pascolo, Zupin, Melato, Tricarico, Crovella (2024.05.13.593942v2.25) 2020; 99 Pisano, Romano, Di Palo, Baroni, Serpico, Contaldo (2024.05.13.593942v2.30) 2023; 11 Khan, Fidel Jr, Al Thunayyan, Meiller, Jabra-Rizk (2024.05.13.593942v2.31) 2013; 4 Amorim Dos Santos, Normando, Carvalho da Silva, De Paula, Cembranel, Santos-Silva (2024.05.13.593942v2.1) 2020; 97 Fidel (2024.05.13.593942v2.22) 2006; 19 Brandini, Takamiya, Thakkar, Schaller, Rahat, Naqvi (2024.05.13.593942v2.6) 2021; 31 Sabatini, Azen (2024.05.13.593942v2.13) 1994; 4 Gaffen, Moutsopoulos (2024.05.13.593942v2.32) 2020; 5 Corchuelo, Ulloa (2024.05.13.593942v2.26) 2020; 100 Jabra-Rizk, Kong, Tsui, Nguyen, Clancy, Fidel (2024.05.13.593942v2.19) 2016; 84 Sultan, Kong, Rizk, Jabra-Rizk (2024.05.13.593942v2.9) 2018; 14 Alfaifi, Sultan, Montelongo-Jauregui, Meiller, Jabra-Rizk (2024.05.13.593942v2.38) 2022; 12 Nikawa, Jin, Fukushima, Makihira, Hamada (2024.05.13.593942v2.17) 2001; 16 Salehi, Ahmadikia, Badali, Khodavaisy (2024.05.13.593942v2.2) 2020; 185 Song, Li, Huang, Chen, Li, Liu (2024.05.13.593942v2.23) 2020; 92 Pavlova, Sharafutdinov (2024.05.13.593942v2.33) 2020; 8 Kong, Tsui, Boyce, Ibrahim, Hoag, Karlsson (2024.05.13.593942v2.34) 2015; 60 Riad, Gad, Ockova, Klugar (2024.05.13.593942v2.4) 2020; 15 Edgerton, Koshlukova, Lo, Chrzan, Straubinger, Raj (2024.05.13.593942v2.15) 1998; 272 Helmerhorst, Troxler, Oppenheim (2024.05.13.593942v2.16) 2001; 98 Vila, Rizk, Sultan, Jabra-Rizk (2024.05.13.593942v2.7) 2019; 15 Ahmad, Piludu, Oppenheim, Helmerhorst, Hand (2024.05.13.593942v2.12) 2004; 52 Tsuchiya (2024.05.13.593942v2.27) 2021; 9 Salvatori, Puri, Tati, Edgerton (2024.05.13.593942v2.8) 2016; 95 Fidel (2024.05.13.593942v2.21) 2002; 8 da Silva Pedrosa, Sipert, Nogueira (2024.05.13.593942v2.24) 2021; 93 Huang, Pérez, Kato (2024.05.13.593942v2.28) 2021; 27 Edgerton, Koshlukova, Araujo, Patel, Dong, Bruenn (2024.05.13.593942v2.14) 2000; 44 Sultan, Rizk, Vila, Ji, Masri, Jabra-Rizk (2024.05.13.593942v2.35) 2019; 87 Amorim Dos Santos, Normando, Carvalho da Silva, Acevedo, De Luca Canto, Sugaya (2024.05.13.593942v2.5) 2021; 100 Peters, Shirtliff, Jabra-Rizk (2024.05.13.593942v2.10) 2010; 6 Oppenheim, Xu, McMillian, Levitz, Diamond, Offner (2024.05.13.593942v2.11) 1988; 263 Stein, Ramelli, Grazioli, Chung, Singh, Yinda (2024.05.13.593942v2.37) 2022; 612 Sultan, Vila, Hefni, Karlsson, Jabra-Rizk (2024.05.13.593942v2.36) 2019; 63 |
References_xml | – volume: 4 start-page: 12 issue: 1 year: 1994 end-page: 9 ident: 2024.05.13.593942v2.13 article-title: Two coding change mutations in the HIS2(2) allele characterize the salivary histatin 3-2 protein variant publication-title: Human Mutation – volume: 8 start-page: 69 issue: Suppl 2 year: 2002 end-page: 75 ident: 2024.05.13.593942v2.21 article-title: Immunity to Candida publication-title: Oral Dis – volume: 16 start-page: 250 year: 2001 end-page: 2 ident: 2024.05.13.593942v2.17 article-title: Antifungal activity of histatin-5 against non-albicans Candida species publication-title: Oral Microbiol Immunol – volume: 92 start-page: 2556 issue: 11 year: 2020 end-page: 66 ident: 2024.05.13.593942v2.23 article-title: Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2 publication-title: J Med Virol – volume: 8 start-page: 1340 issue: 9 year: 2020 ident: 2024.05.13.593942v2.33 article-title: Recognition of Candida albicans and role of innate type 17 immunity in oral candidiasis publication-title: Microorganisms – volume: 84 start-page: 2724 issue: 10 year: 2016 end-page: 39 ident: 2024.05.13.593942v2.19 article-title: Candida albicans pathogenesis: Fitting within the host-microbe damage response framework publication-title: Infect Immun – volume: 31 start-page: e2226 issue: 6 year: 2021 ident: 2024.05.13.593942v2.6 article-title: Covid-19 and oral diseases: Crosstalk, synergy or association? publication-title: Rev Med Virol – volume: 98 start-page: 14637 issue: 25 year: 2001 end-page: 42 ident: 2024.05.13.593942v2.16 article-title: The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species publication-title: Proc Nat Acad Sci – volume: 8 start-page: e166540 issue: 24 year: 2023 ident: 2024.05.13.593942v2.29 article-title: Evidence of a Sjögren’s disease-like phenotype following COVID-19 in mice and humans publication-title: JCI Insight – volume: 97 start-page: 326 year: 2020 end-page: 8 ident: 2024.05.13.593942v2.1 article-title: Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? publication-title: Int J Infect Dis – volume: 100 start-page: 154 year: 2020 end-page: 7 ident: 2024.05.13.593942v2.26 article-title: Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report publication-title: Int J Infect Dis – volume: 100 start-page: 141 issue: 2 year: 2021 end-page: 54 ident: 2024.05.13.593942v2.5 article-title: Oral manifestations in patients with COVID-19: A living systematic review publication-title: Dent Res – volume: 6 start-page: e1001067 issue: 10 year: 2010 ident: 2024.05.13.593942v2.10 article-title: Antimicrobial peptides: Primeval molecules or future drugs? publication-title: PLoS Pathog – volume: 11 start-page: 846 issue: 13 year: 2023 ident: 2024.05.13.593942v2.30 article-title: Oral candidiasis in adult and pediatric patients with COVID-19 publication-title: Biomedicines – volume: 185 start-page: 607 issue: 4 year: 2020 end-page: 11 ident: 2024.05.13.593942v2.2 article-title: Opportunistic fungal Infections in the epidemic area of COVID-19: A cinical and diagnostic perspective from Iran publication-title: Mycopathologia – volume: 6 start-page: pii issue: 1 year: 2020 end-page: E15 ident: 2024.05.13.593942v2.20 article-title: Oral candidiasis: A disease of opportunity publication-title: J Fungi (Basel) – volume: 63 start-page: 771 issue: 8 year: 2020 end-page: 8 ident: 2024.05.13.593942v2.3 article-title: Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern publication-title: Mycoses – volume: 44 start-page: 3310 issue: 12 year: 2000 end-page: 6 ident: 2024.05.13.593942v2.14 article-title: Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways publication-title: Animicrob Agents Chemother – volume: 95 start-page: 365 issue: 4 year: 2016 end-page: 71 ident: 2024.05.13.593942v2.8 article-title: Innate immunity and saliva in Candida albicans-mediated oral diseases publication-title: J Dent Res – volume: 44 start-page: 1485 issue: 6 year: 2000 end-page: 93 ident: 2024.05.13.593942v2.18 article-title: In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1 publication-title: Animicrob Agents Chemother – volume: 93 start-page: 204 issue: 1 year: 2021 end-page: 5 ident: 2024.05.13.593942v2.24 article-title: Are the salivary glands the key players in spreading COVID-19 asymptomatic infection in dental practice? publication-title: J Med Virol – volume: 19 start-page: 80 year: 2006 end-page: 4 ident: 2024.05.13.593942v2.22 article-title: Candida-host interactions in HIV disease: Relationships in oropharyngeal candidiasis publication-title: Adv Dent Res – volume: 99 start-page: 1120 issue: 10 year: 2020 end-page: 1 ident: 2024.05.13.593942v2.25 article-title: TMPRSS2 and ACE2 coexpression in SARS-CoV-2 salivary glands infection publication-title: J Dent Res – volume: 9 start-page: 32 issue: 3 year: 2021 ident: 2024.05.13.593942v2.27 article-title: Oral symptoms associated with COVID-19 and their pathogenic mechanisms: A literature review publication-title: Dent J (Basel – volume: 5 start-page: eaau4594 issue: 43 year: 2020 ident: 2024.05.13.593942v2.32 article-title: Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity publication-title: Sci Immunol – volume: 272 start-page: 20438 issue: 32 year: 1998 end-page: 47 ident: 2024.05.13.593942v2.15 article-title: Candidacidal activity of salivary histatins publication-title: J Biol Chem – volume: 60 start-page: 881 issue: 2 year: 2015 end-page: 9 ident: 2024.05.13.593942v2.34 article-title: Development and in vivo evaluation of a novel histatin-5 bioadhesive hydrogel formulation against oral candidiasis publication-title: Antimicrob Agents Chemother – volume: 612 start-page: 758 issue: 7941 year: 2022 end-page: 63 ident: 2024.05.13.593942v2.37 article-title: SARS-CoV-2 infection and persistence in the human body and brain at autopsy publication-title: Nature Biotech – volume: 14 start-page: e1006719 issue: 1 year: 2018 ident: 2024.05.13.593942v2.9 article-title: The oral microbiome: A lesson in co-existence publication-title: PLoS Pathog – volume: 15 issue: 11 year: 2019 ident: 2024.05.13.593942v2.7 article-title: The power of saliva: Antimicrobial and beyond publication-title: Plos Pathog – volume: 63 start-page: e00888 issue: 10 year: 2019 end-page: 19 ident: 2024.05.13.593942v2.36 article-title: Evaluation of the antifungal and wound healing properties of a novel peptide-based bioadhesive hydrogel formulation publication-title: Antimicrob Agents Chemother – volume: 87 start-page: e00617 issue: 12 year: 2019 end-page: 19 ident: 2024.05.13.593942v2.35 article-title: Digital design of a universal rat intraoral device for therapeutic evaluation of topical formulation against Candida-associated denture stomatitis publication-title: Infect Immun – volume: 52 start-page: 361 issue: 3 year: 2004 end-page: 70 ident: 2024.05.13.593942v2.12 article-title: Immunocytochemical localization of histatins in human salivary glands publication-title: J Histochem Cytochem – volume: 12 start-page: 831744 year: 2022 ident: 2024.05.13.593942v2.38 article-title: Long-term post-COVID-19 associated oral inflammatory sequelae publication-title: Front Cell Infect Microbiol – volume: 15 start-page: 465 issue: 3 year: 2020 end-page: 466 ident: 2024.05.13.593942v2.4 article-title: Oral candidiasis in non-severe COVID-19 patients: Call for antibiotic stewardship publication-title: Oral Surg – volume: 4 start-page: 1 issue: 2 year: 2013 end-page: 6 ident: 2024.05.13.593942v2.31 article-title: Impaired histatin-5 level and salivary antimicrobial activity against C. albicans in HIV-infected individuals publication-title: J AIDS Clin Res – volume: 263 start-page: 7472 issue: 16 year: 1988 end-page: 7 ident: 2024.05.13.593942v2.11 article-title: Histatins, a novel family of histidine-rich proteins in human parotid secretion publication-title: J Biol Chem – volume: 27 start-page: 892 issue: 5 year: 2021 end-page: 903 ident: 2024.05.13.593942v2.28 article-title: SARS-CoV-2 infection of the oral cavity and saliva publication-title: Nat Med |
SSID | ssj0002961374 |
Score | 1.875494 |
SecondaryResourceType | preprint |
Snippet | Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species.... |
SourceID | biorxiv proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
SubjectTerms | Microbiology |
Title | SARS-CoV-2 Infection of Salivary Glands Compromises Oral Antifungal Innate Immunity and Predisposes to Oral Candidiasis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38798323 https://www.proquest.com/docview/3060750278 https://www.biorxiv.org/content/10.1101/2024.05.13.593942 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA_iEHzz-3tE8LXSfLRNH3VsboJzbCp7K0mTwkDa0c2P_ffetXX4oOBbKbmGXu4uv-S-CLkKnfUt4AxPaV94KCGeYk57odaw3cVWMIf5zg_DsP8s76fB9EerLwyrNLOi_Jy9V358DNgG61srt8_wrC6x1CYT10EsYgnWtwUixbFrQ296vb5e4THsU5Fs_Ji_UgLibWb6G11Wu0xvh7RGeu7KXbLh8j2yVbeJXO2Tj8nNeOJ1iheP00ETPJXTIqMTjY6cckXvqoxdispdFrBybkEfS_1KbzAUCNQZHgd5DrCSDqp8kOWKAgEdlZiVOy9w_LKoSTqY5wJCs5gtDshzr_vU6XtNwwTPVIdKK8IwMkyaIDR-CtgqsxZ7HSobp4EwVjHfMh5lmlurU2V9Bito0sgA7pCYlHtINvMid8eEhgHWPuOpNCqTOpQaLAFnlmkVpTwL4hNy2TAvmddlMRJkcOIHCRNJzWAY883WBH4dPRE6d8XbIoFzCkIVHqkTclTze_0ZoaIYzIw4_ccMZ2Qb32HoFmPnZHNZvrkLAAlL0yat2-5wNG5XYvEFDaK25w |
linkProvider | Cold Spring Harbor Laboratory Press |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8QwEA4eiL55u54RfO3SHG3TR1lcd71xVfatJE0KC9Iu7Xrsv3emrT4p-FZo0tDJZObLzDcJIWehs74FnOEp7QsPNcRTzGkv1BrcXWwFc1jvfHsXDp7l1TgYtwG3qqVVmklRfk7e6zw-ErbB-jaL22e4V5d41CYT3SAWseRdDFMvkmXQK4aUrv64-xNj4TE4q0i2ycxfuwPsbYf7G2LWrqa_TpYf9NSVG2TB5Ztkpbkrcr5FPkbnjyOvV7x4nA5bBlVOi4yONGZzyjm9rMt2Ka7wsoDpcxW9L_UrPUc-EKxpeBzmOWBLOqyLQmZzCh3oQ4mludMC28-KpksPi11Ac6pJtU2e-xdPvYHX3prgmXpnaUUYRoZJE4TGTwFgZdbihYfKxmkgjFXMt4xHmebW6lRZn8E0mjQyAD4kVubukKW8yN0eoWGAB6DxVBqVSR1KDeaAM8u0ilKeBXGHnLbCS6bN2RgJCjjxg4SJpBEwtPkWawK_jukInbvirUpgs4J4hUeqQ3Ybef98RqgoBlsj9v8xwglZHTzd3iQ3w7vrA7KG75HLxdghWZqVb-4IUMPMHNeq8QXANbok |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwELVYBOLGTlmNxDVVvCRxjqhQKGtFAfUW2bEjVUJJlZalf89MEhAHkLhF8qaMZ-xnzzwPISehs74FnOEp7QsPNcRTzGkv1Bq2u9gK5pDvfHsXXj7Jq2Ew_MGFwbBKMyrKj9Fb5cfHgG1YfWvj9hme1SU-tclEO4hFLHkbr6nbY5vNk0XQLYaa3R22v-9ZeAwbViQbh-avXQD0bYb8G2ZW2013lSz29diVa2TO5etkqc4XOdsg74PTh4HXKZ49TntNFFVOi4wONHp0yhm9qKi7FK28LGAK3YTel_qFnmJMENg1fPbyHPAl7VXEkOmMQgPaL5GeOy6w_rSom3SQ8ALaMxlNNslT9_yxc-k1mRM8U50urQjDyDBpgtD4KYCszFpMeqhsnAbCWMV8y3iUaW6tTpX1GUylSSMDAEQiO3eLLORF7nYIDQN8BI2n0qhM6lBqWBI4s0yrKOVZELfIcSO8ZFy_j5GggBM_SJhIagFDnS-xJvDr6JLQuSteJwkcWBCz8Ei1yHYt7-9uhIpiWG_E7j9GOCLL_bNuctO7u94jK1iM4VyM7ZOFafnqDgA4TM1hpRmflcK7NQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SARS-CoV-2+Infection+of+Salivary+Glands+Compromises+Oral+Antifungal+Innate+Immunity+and+Predisposes+to+Oral+Candidiasis&rft.jtitle=bioRxiv&rft.au=Alfaifi%2C+Areej+A&rft.au=Wang%2C+Tristan+W&rft.au=Perez%2C+Paola&rft.au=Sultan%2C+Ahmed+S&rft.date=2024-06-11&rft.issn=2692-8205&rft.eissn=2692-8205&rft_id=info:doi/10.1101%2F2024.05.13.593942&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2692-8205&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2692-8205&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2692-8205&client=summon |